GlaxoSmithKline PLC — Director's Dealing 2019

Dec 13, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8931W

GlaxoSmithKline PLC

13 December 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr J Symonds
b)	Position/status	Non-Executive Chairman
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares beneficially held for Mr Symonds in his Zeneca Retirement Capital Plan to his personal shareholding account for nil consideration.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
	£0.00	9,027
d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2019-12-10
f)	Place of the transaction	N/A

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQXLFFKLFZFBQ